Human HIV Vaccine Trial Begins With BRILLIANT 011

Original Article by Yoliswa Sobuwa | Sunday Times | 1 February 2026

South Africa launches the HIV vaccine trial, BRILLIANT 01, testing a new vaccine cocktail designed to prime broadly neutralising antibodies.

South Africa launches the HIV vaccine trial, BRILLIANT 01, testing a new vaccine cocktail designed to prime broadly neutralising antibodies.

Subscription Required

You must be a subscriber to access all of this content.

View Subscriptions

Already a subscriber? Log in here

More Posts

NHLS Scrambles as Pathology Services Funding Runs Dry

The NHLS is scrambling for new providers after funds for haematology pathology services ran dry, amid an R11.3bn provincial debt

Read more...

Momentum Group Posts Record Earnings

Momentum Group has posted record earnings, with normalised headline earnings up 13% to R7.06bn – beating its R7bn Impact target a year early.

Read more...

Sanlam Writes Down AfroCentric to Nil but Won’t Sell

Sanlam has written its AfroCentric stake down to nil after the Bonitas exit but rules out a sale, betting it can revive the business.

Read more...